BCEIE › News › FORTIS

M&A

Fortis Healthcare: Fortis acquires 110-bedded Suguna Hospital, Rajajinagar, Bengaluru for approx. INR 277 Crs; facility…

Fortis Healthcare (FORTIS) filed a disclosure titled "Fortis acquires 110-bedded Suguna Hospital, Rajajinagar, Bengaluru for approx. The company is valued at about ₹57,339 crore.

BCEIE News Desk · Published 28 Oct 2026, 07:29 pm IST · Filing received 28 Oct 2026, 07:12 pm IST

What happened

Fortis Healthcare (FORTIS) filed a disclosure with the exchanges on 28 October 2026 at 07:12 PM titled "Fortis acquires 110-bedded Suguna Hospital, Rajajinagar, Bengaluru for approx. INR 277 Crs; facility provides further potential to scale up to 150 beds".

From the filing: "Fortis Healthcare Limited has informed the Exchange regarding a press release dated October 28, 2026, titled "Fortis acquires 110-bedded Suguna Hospital, Rajajinagar, Bengaluru for approx."

Company snapshot

Fortis Healthcare is a mid-cap company in the Healthcare sector, with a market value of about ₹57,339 crore.

The stock last traded at ₹759.5, against a 52-week range of ₹705–₹1,067.7 (28.9% below the high).

Before this filing the shares had moved −17.8% over the month and −22.0% over three months. Average daily turnover over the last 20 sessions was about ₹174 crore.

Promoters held 31.17% at the end of Q1 FY27. Foreign institutions owned 25.20% and domestic institutions 32.23%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY262,167260.33.45
Q2 FY262,331321.94.26
Q3 FY262,265193.72.57
Q4 FY262,365265.93.52
Q1 FY272,545266.43.53

What history shows

BCEIE's records show 3 previous m&a filings from the company since May 2026.

Across 148 similar disclosures by other Healthcare companies, shares moved +0.6% on average the next day and +0.9% over five days; 57% of them rose the next day.

Market-wide, 2,167 m&a filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Regulatory approvals, completion of the deal and its effect on revenue and margins.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Fortis Healthcare Limited